Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

CMV pp65 peptide

Known as: CMV N495 Peptide, CMV-PEP 
A peptide derived from cytomegalovirus (CMV) internal matrix protein pp65. CMV pp65 peptide antigen is used in recombinant vaccinia virus as an HLA-A… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
BACKGROUND Cytomegalovirus (CMV) is a leading cause of congenital infection and an important target for vaccine development… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Highly Cited
2011
Highly Cited
2011
Human cytomegalovirus (CMV) establishes persistent, usually asymptomatic, infection in healthy people. Because CMV infection is… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2009
Highly Cited
2009
Cardiomyocytes (CMs) are nonregenerative. Self-renewable pluripotent human embryonic stem cells (hESCs) can differentiate into… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2008
Highly Cited
2008
BACKGROUND VCL-CB01, a candidate cytomegalovirus (CMV) DNA vaccine that contains plasmids encoding CMV phosphoprotein 65 (pp65… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Highly Cited
2007
Highly Cited
2007
Abstract: We have developed a novel diagnostic technology to monitor the human cytomegalovirus (HCMV)‐specific CD8+ T‐cell… Expand
Highly Cited
2001
Highly Cited
2001
The major matrix phosphoprotein 65 (pp65) of cytomegalovirus (CMV) is an important target of HLA-restricted cytotoxic T cells… Expand
Highly Cited
2000
Highly Cited
2000
Radioiodide concentrating activity in the thyroid, mediated by human Na+/I− symporter (hNIS), provides a mechanism for effective… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2000
Highly Cited
2000
Study Design. Human intervertebral disc cells were cultured in monolayer and treated with adenovirus-containing marker genes to… Expand
Highly Cited
1999
Highly Cited
1999
A phase I randomized, double-blind, placebo-controlled trial was done with a cytomegalovirus (CMV) vaccine based on the envelope… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Highly Cited
1987
Highly Cited
1987
To study the importance of transferred immunity against cytomegalovirus (CMV) in allogeneic, HLA-matched, T-cell-depleted bone… Expand